Celltrion, Inc. (068270.KS)

KSE · Healthcare · Biotechnology
213,000.00 KRW-0.93%As of 2026-11-22 · KRW
Last session low 211,000.00 KRWLast session high 216,500.00 KRW
52-week low 158,500.00 KRW52-week high 239,047.62 KRW
Market cap (USD)
$36.00B
Sector
Healthcare
Dividend yield
0.34%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in KRW.

IndicatorValueReading
RSI (14)61.6In the neutral range (30 to 70)
MACD (12, 26, 9)6442.87Above its signal line (6064.69); histogram 378.18
Bollinger %B (20, 2)74%Inside the bands (182,681.71 to 223,688.29)
SMA 20203,185.00Price is 4.8% above
SMA 50191,278.00Price is 11.4% above
SMA 200190,369.50Price is 11.9% above
ATR (20)3.39% of priceAverage true range per day
52-week position68%In the upper part of the 158,500.00 to 239,047.62 range

About Celltrion, Inc.

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

Latest fiscal yearEnded 2025-12-31: revenue of 4.16T KRW and an operating margin of 27.8%.

More in Biotechnology